•
Dec 31, 2018

Emergent BioSolutions Q4 2018 Earnings Report

Total Revenue
$271M
Previous year: $194M
+39.7%
EPS
$0.75
Previous year: $0.74
+1.4%
Adjusted EBITDA
$76.2M
Gross Profit
$158M
Previous year: $124M
+27.5%
Cash and Equivalents
$112M
Previous year: $178M
-37.1%
Free Cash Flow
-$187M
Previous year: $66.5M
-380.6%
Total Assets
$2.23B
Previous year: $1.07B
+108.3%

Emergent BioSolutions

Emergent BioSolutions

Emergent BioSolutions Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income